Phibro Animal Health | PAHC - Zinsaufwendungen Für Schuld





Zinsaufwendungen Für Schuld Veränderung Datum
Align Technology USD 16.04M 14.04M 2025-12
ANI Pharmaceuticals USD 4.41M 316K 2025-12
Aurora Cannabis CAD 230K 1.88M 2026-03
Bristol-Myers Squibb USD 411M 21M 2026-03
Canopy Growth CAD 12.31M 4.97M 2026-03
Corcept Therapeutics USD 814.88M 809.46M 2026-03
Eli Lilly USD 114.7M 134.3M 2025-09
Henry Schein USD 39M 0 2026-03
Idexx Laboratories USD 7.74M 2.34M 2026-03
Knight Therapeutics CAD 3.92M 1.56M 2025-12
Merck USD 479M 67M 2026-03
Nektar Therapeutics USD 9.77M 3.75M 2025-12
Pacira USD 3.7M 193K 2026-03
Phibro Animal Health USD 11.91M 191K 2025-12
Prestige Brands USD 10.67M 636K 2025-12
Supernus Pharmaceuticals USD 910K 278K 2023-06
Zoetis USD 62M 5M 2026-03